| Serial Number | 79348994 |
| Word Mark | NEURACTHEL |
| Filing Date | Thursday, April 7, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, January 9, 2024 |
| Registration Number | 7265343 |
| Registration Date | Tuesday, January 9, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 24, 2023 |
| Certificate of Correction for Registration | In statement classes 03, 05, and 10, have been updated per the f-note dated 6/24/24 |
| Goods and Services | Pharmaceuticals *for the prevention and treatment of neurological, endocrinological, and degenerative disorders;* pharmaceutical drugs *for the prevention and treatment of epidermal problems, and damaged skin and tissue;* pharmaceutical products for endocrine, neuroendocrine, systemic, inflammatory, and acute disorders such as sepsis, shock, haemorrhagic shock, acute bleeding disorders, and chronic disorders requiring prevention, curative or palliative treatment where no other treatments are effective or safe; pharmaceutical preparations *for the prevention and treatment of viral, metabolic, genetic, endocrine, musculoskeletal, ophthalmic, cardiovascular, cerebrovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders;* pharmaceuticals used for cerebrovascular accidents *in the nature of strokes*; pharmaceutical preparations for the prevention and treatment of arterial ischemic strokes; medicines for the treatment of cardiovascular and cerebrovascular diseases; pharmaceutical preparations for the prevention and treatment of cardiovascular and cerebrovascular diseases; cardiovascular drugs for use in treating hypertension; cardiovascular preparations *for the prevention and treatment of cardiometabolic conditions;* cardiovascular pharmaceuticals *for the prevention and treatment of ischemic syndromes;* cardiovascular pharmaceutical preparations *for the prevention and treatment of cardiomyopathies;* cardiovascular agents for medical purposes; cardiovascular drugs used in treating *cardiogenic shocks;* cardiovascular drugs used in myocardial infarctions; cardiovascular drugs used in treating arrhythmias; cardiovascular drugs used in angina pectoris; cardiovascular drugs used in treating congestive heart failure (CHF); pharmaceutical preparations containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; medicated sun care preparations, namely, sun tanning preparations for pharmaceutical purposes containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; pharmaceutical preparations for skin care; pharmaceutical preparations for treating skin disorders; *dermatologicals, namely, dermatological preparations, dermatological pharmaceutical substances, dermatological pharmaceutical products;* medicinal creams for the protection of the skin; skin care creams for medical use; skin care preparations for medical use; medicated skin creams and lotions; medicated *skin care* creams for application after exposure to the sun; pharmaceutical skin lotions; preparations for cleansing the skin for medical use; *medicated chemical and biological skin care preparations and chemical reagents* for medical purposes which contain analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; *drug afamelanotide in aqueous and gel formulations;* pharmaceutical implants *comprising living tissue;* subcutaneous implants containing *living tissue and also containing* afamelanotide; implantable *subcutaneous drug delivery devices sold filled with pharmaceutical preparations for the prevention and treatment of neurological, endocrinological, and degenerative disorders; implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations and containing afamelanotide for the prevention and treatment of skin related diseases and disorder* |
| Goods and Services | Non-medicated cosmetics; cosmetics for protecting against light and UV; cosmetics, namely, cosmetic products as leave-on, lotions, creams, ointments and other formulations as well as cosmetic products for topical use; non-medicated *skin care* preparations for protecting the skin against light and UV; non-medicated skin *care* photoprotection preparations; *non-medicated* sun care preparations for cosmetic use; sun-tanning preparations; *cosmetic* suntan lotions; suntan oils *for cosmetic purposes;* tanning gels; cosmetic preparations for skin care containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetics for tanning the skin containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetic preparations for tanning the skin without sunlight containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; sun screen preparations; cosmetic preparations for protecting the skin from the sun's rays; cosmetics for protecting the skin from sunburn; sun protecting creams; sun *block preparations;* sun block; sun blocking preparations; sun-block lotions; sun blocking oils; SPF sun block sprays; *lip balm with sun block;* sun blocking lipsticks; *cosmetic sunscreen preparations;* waterproof sunscreen *preparations;* water-resistant sunscreen *preparations;* sunscreen preparations; sunscreen creams; sunscreen lotions; sunscreen sticks; cosmetic foams containing sunscreen *preparations; sunscreen* preparations for protecting the hair from the sun; *nonmedicated cosmetic preparations against sunburns;* non-medicated *sun care preparations* for skin care after exposure to the sun's rays. |
| Goods and Services | Medical apparatus, devices and instruments *for accessing subcutaneous structures of the human body for the purpose of administering medical treatment;* apparatus for drug administration, *namely, drug delivery catheters;* devices for use in the administration of pharmaceuticals, namely, implantable drug delivery ports; controlled rate release apparatus for dispensing pharmaceutical substances, *namely, implantable drug delivery pumps;* medical fluid injectors; injection syringes; medical syringes; implantable subcutaneous drug delivery *ports and pumps* |
| International Class | 003 - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices. |
| US Class Codes | 001, 004, 006, 050, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 9, 2022 |
| Primary Code | 003 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 9, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 9, 2022 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Clinuvel Europe Ltd |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | IE |
| Party Name | Clinuvel Europe Ltd |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | IE |
| Party Name | Clinuvel Europe Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | IE |
| Event Date | Event Description |
| Wednesday, February 1, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, September 8, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, September 9, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 13, 2022 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, January 25, 2023 | ASSIGNED TO EXAMINER |
| Thursday, February 2, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, March 28, 2023 | REFUSAL PROCESSED BY MPU |
| Tuesday, March 28, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, April 20, 2023 | REFUSAL PROCESSED BY IB |
| Thursday, September 14, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, September 14, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, September 14, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, September 14, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, September 14, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, September 14, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, September 14, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, September 14, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, September 15, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 4, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, October 4, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Tuesday, October 24, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 24, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 24, 2023 | NOTIFICATION PROCESSED BY IB |
| Wednesday, October 4, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 9, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, January 9, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, April 9, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Monday, June 24, 2024 | FINAL DISPOSITION PROCESSED |
| Monday, June 24, 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| Tuesday, June 25, 2024 | CORRECTION UNDER SECTION 7 - PROCESSED |
| Tuesday, July 30, 2024 | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED |
| Sunday, July 14, 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Tuesday, June 25, 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |